Vetigenics
Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Vetigenics Information
Geographic Data
Address:
City: Philadelphia
State: Pennsylvania
Zip:
Country: United States
Financial Info
Stage:
non equity assistance
Raised Last:
$0
Raised Total:$300k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Vetigenics creates novel immunotherapies to treat cancer and other chronic conditions in dogs without the debilitating side effects. Our fully canine phage display platform, enables rapid isolation of unique antibody fragments (scFvs) or CANIBODIES™ to any antigen based binding affinity, functionality and developability. CANIBODIES™ are entirely generated from naïve, canine germline genes, don&s;t require costly, time-consuming caninization and can be readily engineered into mAbs, BiTEs or CAR-T therapies. As a result, our therapies are designed for precision efficacy and lack of immunogenicity, not possible with other discovery technologies. Vetigenics is advancing three internally developed antibody products into the clinic with our 1st in dog studies starting during 1Q21
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
